intraocular hypertension

Noveome Biotherapeutics initiates trial evaluating intranasal delivery of ST266 targeting optic nerve and brain
Pharmaceutical Business Review
Fri, 09/27/19 - 10:44 am
Noveome Biotherapeutics
clinical tirals
ST266
intraocular hypertension